Sofosbuvir

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Sofosbuvir and local guidelines before prescribing.

Direct-acting antiviral (HCV)

Mechanism

NS5B polymerase inhibitor (nucleotide analogue).

Uses

Chronic hepatitis C (combination regimens).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Fatigue, headache, nausea, bradycardia with amiodarone.

Interactions

Amiodarone (severe bradycardia), rifampicin and St John's wort reduce levels.

Contraindications and cautions

Concurrent amiodarone

Monitoring

HCV RNA, HBV markers

Pregnancy and breastfeeding

Avoid with ribavirin

Renal and hepatic impairment

Limited data in severe renal impairment

Overdose and reversal

Supportive

Special advice

Check HBV status before starting; avoid amiodarone.

More from the textbook: uses, cautions and other points
Where it is discussed in the book